BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2662 related articles for article (PubMed ID: 30654001)

  • 21. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
    Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
    Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer.
    Yang X; Wei W; Tan S; Guo L; Qiao S; Yao B; Wang Z
    World J Surg Oncol; 2021 Aug; 19(1):248. PubMed ID: 34419055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Multiple miRNA-Based Signatures for Predicting Overall Survival and Recurrence-Free Survival of Colorectal Cancer Patients.
    Qian J; Zeng L; Jiang X; Zhang Z; Luo X
    Med Sci Monit; 2019 Sep; 25():7258-7271. PubMed ID: 31560680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 35. An age stratified analysis of the biomarkers in patients with colorectal cancer.
    Yao H; Li C; Tan X
    Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
    Xiong Y; You W; Wang R; Peng L; Fu Z
    Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Based on Integrated Bioinformatics Analysis Identification of Biomarkers in Hepatocellular Carcinoma Patients from Different Regions.
    Teng L; Wang K; Liu Y; Ma Y; Chen W; Bi L
    Biomed Res Int; 2019; 2019():1742341. PubMed ID: 31886176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 134.